Marshall Wace’s Guardian Pharmacy Services GRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.51M Sell
35,996
-381,714
-91% -$14.8M ﹤0.01% 2003
2026
Q1
$15.7M Buy
+417,710
New +$13.6M 0.02% 787
2025
Q4
Sell
-139,897
Closed -$3.67M 3607
2025
Q3
$3.67M Buy
139,897
+124,455
+806% +$2.97M ﹤0.01% 1328
2025
Q2
$329K Buy
15,442
+1,883
+14% +$42.5K ﹤0.01% 2301
2025
Q1
$288K Buy
+13,559
New +$278K ﹤0.01% 2284

Other funds holding GRDN

Marshall Wace's GRDN Position: Q2 2026 in Review

Marshall Wace reduced its Guardian Pharmacy Services (GRDN) stake by 91% in Q2 2026, selling an estimated $14.8M and leaving 35,996 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #2003.

Marshall Wace first reported a position in GRDN in Q1 2025 and has held it in 5 quarters since. The position peaked at $15.7M in Q1 2026. 189 funds tracked by Wall St. Rank hold GRDN as of Q2 2026.

  • Marshall Wace held 35,996 shares of Guardian Pharmacy Services worth $1.51M as of Q2 2026.
  • Marshall Wace sold 381,714 Guardian Pharmacy Services shares in Q2 2026, an estimated $14.8M.
  • Guardian Pharmacy Services made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2003 holding.
  • Marshall Wace first reported a position in Guardian Pharmacy Services in Q1 2025 and has held it in 5 quarters since.
  • Marshall Wace's Guardian Pharmacy Services position peaked at $15.7M in Q1 2026.
  • 189 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.